Emerald Health Therapeutics’ Quebec Cannabis Operation Receives License Expansion for Total Facility Area
07 oct. 2019 07h00 HE
|
Emerald Health Therapeutics Inc.
VANCOUVER, British Columbia, Oct. 07, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics’ (“Emerald”)(TSXV: EMH; OTCQX: EMHTF) wholly-owned cannabis production facility, Verdélite, in St....
Emerald Health Therapeutics reçoit un permis de culture pour une nouvelle exploitation de cannabis biologique en Colombie-Britannique
24 juin 2019 07h21 HE
|
Emerald Health Therapeutics Inc.
VANCOUVER, Colombie-Britannique, 24 juin 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (« Emerald ») (TSXV : EMH ; OTCQX : EMHTF) a reçu son permis de culture initial de la part de...
Emerald Health Therapeutics Receives Cultivation License for New-Build Organic Cannabis Operation in British Columbia
24 juin 2019 07h00 HE
|
Emerald Health Therapeutics Inc.
VANCOUVER, British Columbia, June 24, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) has received its initial cultivation license from Health Canada...
Emerald Health Therapeutics signe des contrats visant la récolte de 1 200 acres de chanvre au Canada, fait état de progrès importants au sujet des installations d'extraction de Factors Group et crée une filiale américaine exerçant des activités dans le domaine du chanvre
12 juin 2019 15h58 HE
|
Emerald Health Therapeutics Inc.
VANCOUVER, Colombie-Britannique, 12 juin 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (« Emerald ») (TSXV : EMH; OTCQX : EMHTF) annonce avoir élargi son entente visant l'achat de...
Emerald Health Therapeutics Contracts for 1,200 Acres of Canadian Hemp Harvest, Reports Significant Progress on Factors Group Extraction Facility, and Forms US Hemp Subsidiary
12 juin 2019 07h00 HE
|
Emerald Health Therapeutics Inc.
VANCOUVER, British Columbia, June 12, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) reports that is has expanded its agreement to purchase...
Wereldhave repaid its maturing €250m convertible bond in full
23 mai 2019 01h07 HE
|
Wereldhave N.V.
Wereldhave repaid its maturing €250m convertible bond in full On 22 May 2019 Wereldhave N.V. repaid its maturing €250m convertible bond in full. None of the bondholders exercised its conversion...
Emerald Health Therapeutics Receives Standard Processing License for Verdélite Facility in Quebec
08 avr. 2019 07h00 HE
|
Emerald Health Therapeutics Inc.
VANCOUVER, British Columbia, April 08, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) today announced that its Québec facility, Verdélite, has...
Emerald Health Therapeutics Sees Pure Sunfarms Licensed for 1.03 Million Square Feet of Cannabis Cultivation; Full Planting Targeted for End of April
11 mars 2019 07h00 HE
|
Emerald Health Therapeutics Inc.
VICTORIA, British Columbia, March 11, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV:EMH; OTCQX:EMHTF) today announced that its 50%-owned joint venture for large-scale,...
Emerald Health Therapeutics Launches 88,000 Square Foot State-of-the-Art, Fully-Integrated Indoor Facility and Verdélite Brand in Québec
20 févr. 2019 06h00 HE
|
Emerald Health Therapeutics Inc.
SAINT-EUSTACHE, Québec, Feb. 20, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) today announced the launch of Verdélite Sciences Inc....
Emerald Health sees Expansion of Pure Sunfarms’ Cannabis Cultivation License to 825,000 Square Feet
28 janv. 2019 07h00 HE
|
Emerald Health Therapeutics Inc.
VICTORIA, British Columbia, Jan. 28, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. ("Emerald" or the “Company”) (TSXV:EMH; OTCQX:EMHTF) announced that its 50%-owned joint venture...